Is there still a place for vinorelbine in advanced metastatic castration resistant prostate cancer?

The aim of this paper was to evaluate the activity and tolerability of oral vinorelbine in patients with advanced castration resistant prostate cancer (CRPC) who progressed after a minimum of three lines including: abiraterone acetate, docetaxel, cabazitaxel, and enzalutamide. Treatment consisted of...

Full description

Saved in:
Bibliographic Details
Published in:Medicine (Baltimore)
Main Authors: Roviello, Giandomenico, Corona, Silvia Paola, Conca, Raffaele, Petrioli, Roberto, Rosellini, Pietro, Bonetta, Alberto, Aieta, Michele
Format: Artigo
Language:Inglês
Published: Wolters Kluwer Health 2019
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6616091/
https://ncbi.nlm.nih.gov/pubmed/31261590
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000016249
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items